Guidelines for treatment of hospital-acquired pneumonia

Seminars in Respiratory and Critical Care Medicine

Volumn 23, Issue 5, 2002, Pages 457-469

  Brun Buisson, Christian ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Antibiotic use; Antimicrobial resistance; Guidelines; Nosocomial; Pneumonia; Therapy

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; DICLOXACILLIN; IMIPENEM; LINEZOLID; MEROPENEM; NETILMICIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; UREIDOPENICILLIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; CLINICAL FEATURE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MULTIDRUG RESISTANCE; NONHUMAN; PNEUMONIA; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW;

EID: 0036813505     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35717     Document Type: Review

References (73)

1. George DL. Epidemiology of nosocomial ventilator-associated pneumonia. Infect Control Hosp Epidemiol 1993;14:163-169
2. Fagon JY, Chastre J, Trouillet JL, Pierre J, Darne C, Gibert C. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989;139:877-884
3. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care in Europe: Results of the European prevalence of infection in intensive care (EPIC) study. JAMA 1995;274:639-644
4. Alberti C, Brun-Buisson C, Burchardi H, et al. Epidemiology of sepsis and infection in ICU patients from an international multicenter cohort study. Intensive Care Med 2002;28:108-121
5. Bergmans DC, Bonten MJM, Gaillard CA, et al. Indications for antibiotic use in ICU patients: A one-year prospective surveillance. J Antimicrob Chemother 1997;39:527-535
6. Alvarez-Lerma F, the ICU-Acquired Pneumonia Study Group. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med 1996;22:387-394
7. Rello J, Gallego M, Mariscal D, Sonora R, Vallés J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997;156:196-200
8. Sanchez-Nieto JM, Torres A, Garcia-Cordoba F, et al. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: A pilot study. Am J Respir Crit Care Med 1998;157:371-376
9. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: Implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998;113:412-420
10. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997;111:676-685
11. Dupont H, Mentec H, Sollet JP, Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med 2001; 27:355-362
12. Solé-Violan J, Fernandez JA, Benitez AB, Cardenosa Cendrero JA, Rodriguez de Castro F. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med 2000;28:2737-2741
13. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001;134:298-314
14. The Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Intensive Care Antimicrobial Resistance Epidemiology (ICARE) surveillance report, data summary from January 1996 through December 1997. Am J Infect Control 1999;27:279-284
15. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-474
16. Andrews CP, Coalson JJ, Smith JD, Johanson WG. Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury. Chest 1981;80:254-258
17. Delclaux C, Roupie E, Blot F, Brochard L, Lemaire F, BrunBuisson C. Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: Incidence and diagnosis. Am J Respir Crit Care Med 1997;156: 1092-1098
18. Fagon JY, Chastre J, Hance AJ, et al. Detection of nosocomial lung infection in ventilated patients: Use of a protected brush specimen and quantitative culture techniques in 147 patients. Am Rev Respir Dis 1988;138:110-116
19. Meduri GU, Mauldin GL, Wunderink RG, et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest 1994; 106:221-235
20. Torres A, El Ebiary M, Padro L, et al. Validation of different techniques for the diagnosis of ventilator-associated pneumonia: Comparison with immediate post-mortem biopsy. Am J Respir Crit Care Med 1994;149:324-331
21. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991;143:1121-1129
22. Singh N, Falestiny MN, Rogers P, et al. Pulmonary infiltrates in the surgical ICU: Prospective assessment of predictors of etiology and mortality. Chest 1998;114:1120-1136
23. Johanson WG, Seidenfeld JJ, Gomez P, De Los Santos R, Coalson JJ. Bacteriologic diagnosis of nosocomial pneumonia following prolonged mechanical ventilation. Am Rev Respir Dis 1988;137:259-264
24. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course Empiric Antibiotic Therapy for Patients with Pulmonary Infiltrates in the Intensive Care Unit: A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162:505-511
25. Bonten MJ, Froon AHM, Gaillard CA, et al. The systemic inflammatory response in the development of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997;156: 1105-1113
26. Froon AHM, Bonten MJ, Gaillard CA, et al. Prediction of clinical severity and outcome of ventilator-associated pneumonia: Comparison of simplified acute physiology score with systemic inflammatory mediators. Am J Respir Crit Care Med 1998;158:1026-1031
27. Bonten MJ, Bergmans DC, Stobberingh EE, et al. Implementation of bronchoscopic techniques in the diagnosis of ventilator-associated pneumonia to reduce antibiotic use. Am J Respir Crit Care Med 1997;156:1820-1824
28. Blot F, Raynard B, Chachaty E, Tancrede C, Antoun S, Nitenberg G. Value of gram stain examination of lower respiratory tract secretions for early diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 2000;162:1731-1737
29. Lambert RS, Vereen LE, George RB. Comparison of tracheal aspirates and protected brush catheter specimens for identifying pathogenic bacteria in mechanically ventilated patients. Am J Med Sci 1989;297:377-382
30. Chastre J, Fagon JY, Soler P, et al. Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: Comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush. Am J Med 1988;85:499-506
31. Chastre J, Fagon JY, Bornet-Lecso M, et al. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 1995;152:231-240
32. Allaouchiche B, Jaumain H, Dumontet C, Motin J. Early diagnosis of ventilator-associated pneumonia: Is it possible to define a cutoff value of infected cells in BAL fluid? Chest 1996;110:1558-1565
33. Souweine B, Veber B, Bedos JP, et al. Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: Impact of previous antimicrobial treatments. Crit Care Med 1998;26:236-244
34. Timsit JF, Misset B, Renaud B, Goldstein FW, Carlet J. Effect of previous antimicrobial therapy on the accuracy of the main procedures used to diagnose nosocomial pneumonia in patients who are using mechanical ventilation. Chest 1995; 108:1036-1040
35. Chevret S, Hemmer M, Cadet J, Langer M. Incidence and risk factors of pneumonia acquired in intensive care units: Results from a multicenter prospective study on 996 patients. European Cooperative Group on Nosocomial Pneumonia. Intensive Care Med 1993;19:256-264
36. Langer M, Cigada M, Mandelli M, Mosconi P, Tognoni G, the ICUGIC. Early onset pneumonia: A multicenter study in intensive care units. Intensive Care Med 1987;13:342-346
37. Rello J, Diaz E, Roque M, Valles J. Risk factors for developing pneumonia within 48 hours of intubation. Am J Respir Crit Care Med 1999;159:1742-1746
38. Ibrahim EH, Ward S, Sherman G, Kollef MH. A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest 2000;117:1434-1442
39. Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients: Emergence of gramnegative bacilli. N Engl J Med 1969;281:1137-1140
40. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998;157:531-539
41. Bonten MJ, Bergmans DC, Speijer H, Stobberingh EE. Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units: Implications for infection control. Am J Respir Crit Care Med 1999; 160:1212-1219
42. Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: Implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999;160:608-613
43. Pham LH, Brun-Buisson C, Legrand P, et al. Diagnosis of nosocomial pneumonia in mechanically ventilated patients: Comparison of a plugged telescoping catheter with the protected specimen brush. Am Rev Respir Dis 1991;143: 1055-1061
44. Cook DJ, Kollef MH. Risk factors for ICU-acquired pneumonia. JAMA 1998;279:1605-1606
45. Flynn DM, Weinstein RA, Nathan C, Gaston MA, Kabins SA. Patient's endogenous flora as the source of "nosocomial" Enterobacterin cardiac surgery. J Infect Dis 1987;136:363-368
46. Trouillet JL, Vuagnat A, Combes A, Kassis N, Chastre J, Gibert C. Pseudomonas aeruginosa ventilator-associated pneumonia: Comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis 2002;34:1047-1054
47. American Thoracic Society. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies: A consensus statement. Am J Respir Crit Care Med 1996;153:1711-1725
48. Heyland DK, Cook DJ, Marshall JC, et al. The clinical utility of invasive diagnostic techniques in the setting of ventilatorassociated pneumonia. Chest 1999;115:1076-1084
49. Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: A randomized trial. Ann Intern Med 2000;132: 621-630
50. Mier L, Dreyfuss D, Darchy B, et al. Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using protected specimen brush and quantitative cultures. Intensive Care Med 1993;19:279-284
51. Fink MP, Snydman DR, Niederman MS, et al. Treatment of severe pneumonia in hospitalized patients: Results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. Antimicrob Agents Chemother 1994;38:547-557
52. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: Comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 1999;43:1379-1382
53. Fish DN, Piscitelli SC, Danziger LH. Development of resistance during antimicrobial therapy: A review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy 1995;15:279-291
54. Harris AD, Smith D, Johnson JA, Bradham DD, Roghmann MC. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 2002;34: 340-345
55. Wolff M, the Cefpirome Pneumonia Study Group. Comparison of strategies using cefpirome and ceftazidime for empiric treatment of pneumonia in intensive care patients. Antimicrob Agents Chemother 1998;42:28-36
56. Beaucaire G, Nicolas MH, Martin C, et al. Etude phare: Etude comparative de l'association céfépime-amikacine versus ceftazidime en association avec l'amikacine dans le traitement des pneumonies nosocomiales chez les patients ventilés. Ann Fr Anesth Réan 1999;18:186-195
57. Alvarez-Lerma F, Insausti-Ordenana J, Jorda-Marcos R, et al. Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: A prospective randomized multicenter trial. Intensive Care Med 2001;27: 493-502
58. Brun-Buisson C, Sollet JP, Schweich H, Brière S, Petit C, the VAP Study Group. Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: A multicenter, randomized controlled trial. Clin Infect Dis 1998;26:346-354
59. Joshi M, Bernstein J, Solomkin J, Wester BA, Kuye O. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection. Piperacillin/tazobactam Nosocomial Pneumonia Study Group. J Antimicrob Chemother 1999;43:389-397
60. Sieger B, Berman SZ, Geckler RW, Farkas SA, the Meropenem Lower Respiratory Infection Group. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: A randomized study. Crit Care Med 1997;25:1663-1670
61. Fagon J, Patrick H, Haas DW, et al. Treatment of gram-positive nosocomial pneumonia: Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group. Am J Respir Crit Care Med 2000;161:753-762
62. Rubinstein E, Cammarata S, Oliphant T, Wunderink R. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: A randomized, double-blind, multicenter study. Clin Infect Dis 2001;32:402-412
63. Laforce FM. Systemic antimicrobial therapy of nosocomial pneumonia: Monotherapy versus combination therapy. Eur J Clin Microbiol Infect Dis 1989;8:61-68
64. Arbo MD, Snydman DR. Monotherapy is appropriate for nosocomial pneumonia in the intensive care unit. Semin Respir Infect 1993;8:259-267
65. Lynch JPI. Combination therapy is appropriate for nosocomial pneumonia in the intensive care unit. Semin Respir Infect 1993;8:268-284
66. Cometta A, Baumgartner JD, Lew D, et al. Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrob Agents Chemother 1994; 38:1309-1313
67. Hilf M, Yu VL, Sharp J, et al. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: Outcome correlations in a prospective study of 200 patients. Am J Med 1989;87:540-546
68. Moore R, Smith CR, Lietman PS. Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med 1984;77:657-662
69. Kashuba AD, Nafziger AN, Drusano GL, Bertino JS Jr. Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria. Antimicrob Agents Chemother 1999;43:623-629
70. Thomas JK, Forrest A, Bhavnani SM, et al. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother 1998;42:521-527
71. Rello J, Mariscal D, March F, et al. Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: Relapse or reinfection? Am J Respir Crit Care Med 1998;157:912-916
72. Schentag JJ. Antimicrobial management strategies for grampositive bacterial resistance in the intensive care unit. Crit Care Med 2001;29:100-107
73. Ruiz M, Torres A, Ewig S, et al. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: Evaluation of outcome. Am J Respir Crit Care Med 2000;162: 119-125